Company intelligence / Profile preview

Idukern

El Prat de Llobregat, Catalonia, Spain

Ownership: Private
Employees: ~500
Development stage: Other

Overview

Indukern is a prominent Spanish company historically focused on the distribution of fine chemicals and the manufacture of pharmaceutical and veterinary products. Founded in 1962, the company grew into the Indukern Group, which includes Kern Pharma (human pharmaceuticals) and Calier (veterinary health). In 2021, the Indukern chemical distribution division was acquired by the Ravago Group, while the Diaz-Varela family retained ownership of Kern Pharma and Calier. The company provides a wide range of active pharmaceutical ingredients (APIs), excipients, and added-value services to the global life sciences industry.

Modalities: Small moleculeBiologic
Industry: Biotech

Beyond the preview

Go deeper on Idukern.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Idukern.

Explore the full profile